Contact Us

TOURISM NEWS

Apple is hosting its 'It's Glowtime' event TODAY where it could unveil a range of new products including the iPhone 16 and the Apple Watch X - here's how you can watch live

Sep 9, 2024

The big day for Apple fans around the world is finally here, with the iPhone 16 expected to be launched later today.

Countdown to IBC: PGYTECH to Make Its Debut in the Netherlands with the OnePro Series

Sep 9, 2024

AMSTERDAM,Sept. 7,2024-- The 2024 International Broadcasting Convention (IBC 2024) will be held from September 13th to 16th at the RAI Exhibition and Convention Centre in Amsterdam. As Europe\'s larg

TECNO at IFA 2024: Innovative AIoT Ecosystem for AI-powered Trendy Lifestyles and All-new Experiences

Sep 9, 2024

BERLIN,Sept. 6,2024-- Innovative technology brandTECNO is today showcasing its AIoT smart ecosystem at IFA Berlin 2024,demonstrating how its advanced products are paving the way for a better connecte

Antennova to Present Latest Data of ATN-037 in a Mini Oral Presentation at ESMO Congress 2024

Sep 9, 2024

BOSTON,Sept. 9,2024--Antennova,a clinical-stage biotech company focused on oncology today announced that it will present the latest data of CD73 small molecule inhibitor ATN-037 in a Mini Oral presen

ESMO 2024 | Ascentage Pharma to Present Updated Data of Olverembatinib in Patients with SDH-Deficient GIST during a Mini Oral Presentation at the 2024 ESMO Congress

Sep 9, 2024

ROCKVILLE,Md. and SUZHOU,China,Sept. 9,2024-- Ascentage Pharma (6855.HK),a global biopharmaceutical company engaged in discovering,developing and commercializing both first-in-class and best-in-class

Perioperative Ivonescimab (PD-1/VEGF) for NSCLC Demonstrated Clinically Significant Phase II Results, Presented in Oral Session at WCLC 2024

Sep 9, 2024

HONG KONG,Sept. 9,2024-- Akeso (9926. HK) announced that its internally developed PD-1/VEGF bispecific antibody ivonescimab showed clinically significant results from a Phase II study,either as a mono

1 ... 310 311 312 313 314 315 316 ... 382